Developments Liminal BioSciences presents new preclinical data at ASN Kidney Week Liminal BioSciences (TSX:LMNL; OTCQX:PFSCF) and its collaborators presented new preclinical findings on a novel therapeutic approach to the treatment of inflammatory and fibrosis-related kidney diseases at the American... November 11, 2019